CooperN, ArnoldDM. 2010. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. BJH, 149:3–13.
2.
RatermanHG, JamnitskiA, LemsWF, VoskuylAE, DijkmansBA, BosWH, SimsekS, LipsP, van de StadtRJ, de KoningMH, NurmohamedMT. 2011. Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. J Rheumatol, 38:247–251.
3.
SalviM, VannucchiG, CampiI, CurròN, DazziD, SimonettaS, BonaraP, RossiS, SinaC, GuastellaC, RatigliaR, Beck-PeccozP. 2007. Treatment of Grave's disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol, 156:33–40.
